(Q51483995)

English

Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.

scientific article published on 5 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

phase I clinical trial

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Kuppens IE

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Witteveen PO

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Schot M

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Schuessler VM

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Daehling A

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Beijnen JH

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Voest EE

7

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Schellens JH

8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

publication date

5 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

25

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

227-235

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Motor neuropathy due to docetaxel and paclitaxel

1 reference

https://api.crossref.org/works/10.1007%2FS10637-006-9027-2

21 January 2018

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of antitumor drugs that interact with microtubules and tubulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of taxanes in lung-cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity of antineoplastic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapeutic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Past and future of the mitotic spindle as an oncology target

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/17146730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-006-9027-2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17146730

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51483995&oldid=2210864999"